MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 38 filers reported holding MILESTONE PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.71 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,994 | +8.8% | 21,611 | 0.0% | 0.00% | – |
| Q2 2023 | $61,591 | -28.9% | 21,611 | -1.8% | 0.00% | – |
| Q1 2023 | $86,676 | -50.5% | 21,999 | -50.2% | 0.00% | – |
| Q4 2022 | $174,976 | -13.4% | 44,186 | +100.9% | 0.00% | – |
| Q3 2022 | $202,000 | +57.8% | 21,996 | +1.8% | 0.00% | – |
| Q2 2022 | $128,000 | -8.6% | 21,608 | -0.9% | 0.00% | – |
| Q1 2022 | $140,000 | +2.9% | 21,802 | +4.7% | 0.00% | – |
| Q4 2021 | $136,000 | +16.2% | 20,832 | +1.9% | 0.00% | – |
| Q3 2021 | $117,000 | +28.6% | 20,448 | +23.0% | 0.00% | – |
| Q2 2021 | $91,000 | -8.1% | 16,626 | -2.3% | 0.00% | – |
| Q1 2021 | $99,000 | -13.2% | 17,016 | 0.0% | 0.00% | – |
| Q4 2020 | $114,000 | -11.6% | 17,016 | -3.1% | 0.00% | – |
| Q3 2020 | $129,000 | – | 17,562 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 1,750,043 | $11,464,000 | 1.71% |
| Novo Holdings A/S | 2,530,585 | $16,575,000 | 0.78% |
| Boxer Capital, LLC | 2,238,861 | $14,665,000 | 0.57% |
| RTW INVESTMENTS, LP | 4,315,102 | $28,264,000 | 0.41% |
| RA Capital Management | 2,246,503 | $14,715,000 | 0.26% |
| Bleichroeder LP | 250,000 | $1,638,000 | 0.26% |
| PURA VIDA INVESTMENTS, LLC | 931,511 | $6,101,000 | 0.22% |
| Orbimed Advisors | 2,583,821 | $16,924,000 | 0.22% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 851,291 | $5,576,000 | 0.11% |
| Eversept Partners, LP | 147,165 | $963,931 | 0.06% |